Inebilizumab is a monoclonal antibody targeting CD19 with enhanced capabilities for antibody-dependent cell-mediated cytotoxicity (ADCC) directed against B cells. This antibody is utilized in research focused on multiple sclerosis and neuromyelitis optica, providing a valuable tool for studying disease mechanisms and potential therapeutic interventions in these conditions.
Inebilizumab is a monoclonal antibody targeting CD19 with enhanced capabilities for antibody-dependent cell-mediated cytotoxicity (ADCC) directed against B cells. This antibody is utilized in research focused on multiple sclerosis and neuromyelitis optica, providing a valuable tool for studying disease mechanisms and potential therapeutic interventions in these conditions.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
